Nigeria: Extensive resistance common in patients failing antiretroviral therapy

Just over half of a sample of Nigerian patients on failing antiretroviral therapy had extensive cross-resistance to all nucleoside analogues, including tenofovir, according to findings from Nigeria’s national treatment programme presented on Wednesday at the 2008 HIV Implementers’ meeting in Kampala, Uganda.